New HIV drug combo studied in kids for better virus control
NCT ID NCT02016924
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how safe and effective certain HIV medicines are for children and teens (ages 4 weeks to under 18 years) who already have the virus under control. Participants take a combination of drugs (atazanavir or darunavir boosted with cobicistat, plus emtricitabine/tenofovir alafenamide) to keep the virus suppressed. The goal is to find the right doses and confirm the drugs work well in younger patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AMBSO Masaka Clinical Research Site
Masaka, Uganda
-
HIV-NAT
Bangkok, 10330, Thailand
-
Helios Salud
Buenos Aires, C1141 ACG, Argentina
-
Hospital General de Agudos Cosme Argerich
Buenos Aires, 1151, Argentina
-
Imperial College Healthcare NHS Trust
London, W2 1NY, United Kingdom
-
King Edward VIII Hospital
Durban, 3629, South Africa
-
MU-JHU Research Collaboration/MU-JHU Care Ltd
Kampala, 256, Uganda
-
Pediatric Infectious Disease Associates
Long Beach, California, 90806, United States
-
Perinatal HIV Research Unit
Soweto, 2013, South Africa
-
Peter Morton Medical Building
Los Angeles, California, 90095, United States
-
Rahima Clinical Trials, a Division of Wits Health Consortium (Pty) Ltd
Johannesburg, 2093, South Africa
-
SICRA-TASO Mulago National Referral Hospital
Kampala, Uganda
-
Siriraj Hospital
Bangkok, 10700, Thailand
-
Srinagarind Hospital
Khon Kaen, 40002, Thailand
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
The Aurum Institute: Pretoria Clinical Research Centre
Pretoria, 87, South Africa
-
The George Washington University
Washington D.C., District of Columbia, 20010, United States
-
University of Colorado Denver
Aurora, Colorado, 80045, United States
-
University of South Florida
Tampa, Florida, 33606, United States
-
University of Stellenbosch
Cape Town, 7505, South Africa
-
University of Texas Health Science Center of Houston
Houston, Texas, 77030, United States
-
University of Zimbabwe Clinical Research Centre
Harare, Zimbabwe
-
University of the Free State
Bloemfontein, 9300, South Africa